These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34878730)

  • 1. Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir.
    Wang M; Zhang L; Huo X; Zhang Z; Zhang W
    Curr Protoc; 2021 Dec; 1(12):e303. PubMed ID: 34878730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic Asymmetric Synthesis of the anti-COVID-19 Drug Remdesivir.
    Wang M; Zhang L; Huo X; Zhang Z; Yuan Q; Li P; Chen J; Zou Y; Wu Z; Zhang W
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20814-20819. PubMed ID: 32870563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Application of Chiral Bicyclic Imidazole Catalysts.
    Wang M; Zhang Z; Zhang W
    Acc Chem Res; 2022 Sep; 55(18):2708-2727. PubMed ID: 36043467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
    Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Remdesivir for COVID-19.
    Zhang H; Chen J; Wang X; Chen B
    Discov Med; 2021; 31(163):57-60. PubMed ID: 34965372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
    [No Abstract]   [Full Text] [Related]  

  • 7. Remdesivir for patients with COVID-19.
    Wu PE; Morris AM
    CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
    Schloer S; Brunotte L; Mecate-Zambrano A; Zheng S; Tang J; Ludwig S; Rescher U
    Br J Pharmacol; 2021 Jun; 178(11):2339-2350. PubMed ID: 33825201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update Alert 2: Remdesivir for Adults With COVID-19.
    Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
    Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
    [No Abstract]   [Full Text] [Related]  

  • 10. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.
    Saha A; Sharma AR; Bhattacharya M; Sharma G; Lee SS; Chakraborty C
    Arch Med Res; 2020 Aug; 51(6):585-586. PubMed ID: 32439198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients.
    Odeti S; Yellepeddi VK
    Am Fam Physician; 2021 Sep; 104(3):311-312. PubMed ID: 34523893
    [No Abstract]   [Full Text] [Related]  

  • 12. Remdesivir: a pendulum in a pandemic.
    Schwartz IS; Heil EL; McCreary EK
    BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523
    [No Abstract]   [Full Text] [Related]  

  • 13. Remdesivir for COVID-19: Why Not Dose Higher?
    Yan VC; Muller FL
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558301
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
    Camprubí D; Gaya A; Marcos MA; Martí-Soler H; Soriano A; Mosquera MDM; Oliver A; Santos M; Muñoz J; García-Vidal C
    Int J Infect Dis; 2021 Mar; 104():379-381. PubMed ID: 33359065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 16. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R
    Ann Intern Med; 2021 May; 174(5):673-679. PubMed ID: 33560862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment.
    Agoni C; Soliman MES
    Curr Pharm Biotechnol; 2021; 22(11):1520-1537. PubMed ID: 33109039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Remdesivir Derivate as a Generation of Anti-COVID-19 Drugs Through Acetylation Reactions.
    Sumardi R; Rifai Y; Alam G
    Arch Razi Inst; 2023 Dec; 78(6):1753-1761. PubMed ID: 38828177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Miller MC; Forciea MA; Humphrey LL;
    Ann Intern Med; 2021 Dec; 174(12):W116-W117. PubMed ID: 34606308
    [No Abstract]   [Full Text] [Related]  

  • 20. Remdesivir retreatment: another unproven intervention for COVID-19.
    Al-Heeti O; Kumar RN; Kling K; Angarone M; Achenbach C; Taiwo B
    J Antimicrob Chemother; 2022 Feb; 77(3):854-856. PubMed ID: 35022726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.